This study will gather information about patients who are taking new medicines for Alzheimer's disease. We'll keep an eye on how these patients are doing in the long run, tracking things like how they're responding to treatment, what their overall health outcomes are like, and how safe these new treatments really are when used in the real world. The goal of this study is to get a better understanding of how these therapies actually work for a diverse group of people, not just the people who usually participate in clinical trials.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Heidi Roth
Neurology
Clinical or Medical
Registry
Brain, Head, Nervous System
23-2470